Analysts' Actions: ANF BMY CERN FSLR MGM

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abercrombie & Fitch ( ANF) downgraded at Baird from Outperform to Neutral, Robert Baird said. $32 price target. Company is seeing lower sales, especially in Europe.

Abercrombie & Fitch downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $28 price target. Company could continue to struggle for several quarters.

Advantest ( ATE) downgraded to sell at TheStreet Ratings.

BCD Semiconductor Manufacturing ( BCDS) downgraded to sell at TheStreet Ratings.

Bristol-Myers ( BMY) downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Stock could be rangebound, following the failure of its Hepatitis-C treatment.

Cerner ( CERN) downgraded at Leerink to Market Perform, Leerink Swann said. Bookings growth is starting to decelerate.

Embraer ( ERJ) rated new Buy at UBS. $32 price target. Bizjets / defense / aftermarket to drive growth.

First Solar ( FSLR) upgraded at Baird from Neutral to Outperform, Robert Baird said. $30 price target. Company has a solid balance sheet and pipeline execution remains strong.

First Solar upgraded at Cantor from Hold to Buy, Cantor Fitzgerald said. Company can replace its project pipeline and transition to a more sustainable business model.

First Solar upgraded at ThinkEquity from Sell to Hold, ThinkEquity said. $16 price target. Company boosted its guidance and appears to have prior issues under control.

HSN ( HSNI) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.

MGM Resorts ( MGM) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $11 price target. Second half recovery may not materialize in Las Vegas.

Pharmacyclics ( PCYC) downgraded at Needham from Buy to Hold, Needham said. Valuation call.

Ralcorp ( RAH) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $75 price target. Company is cutting costs.

Stryker ( SYK) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $61 price target. Expect a challenging environment for hospital capital spending.

Titanium Metals ( TIE) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $17 price target.

Wright Express ( WXS) downgraded at Sterne Agee to Neutral, Sterne Agee said. $73 price target. Estimates also cut, given macro risks.

STOCK COMMENTS / EPS CHANGES

American Eagle ( AEO) numbers increased at Sterne Agee through 2013, Sterne Agee said. Higher sales are driving margin expansion. Neutral rating and new $21 price target.

Affiliated Managers Group ( AMG) numbers raised at Citigroup. Shares of AMG now seen reaching $135, Citigroup said. Estimates also increased as flow story continues to be robust. Buy rating.

American Tower ( AMT) target raised at Oppenheimer. Shares of AMT now seen reaching $80, Oppenheimer said. Solid growth trends continue. Outperform rating.

Abercrombie & Fitch ( ANF) numbers lowered at Oppenheimer. Shares of ANF now seen reaching $40, Oppenheimer said. Estimates also lowered on disappointing quarter. Outperform rating.

Abercrombie & Fitch numbers lowered at Sterne Agee. ANF estimates were cut through 2013, Sterne Agee said. Sales are sharply decelerating. Neutral rating and new $34 price target.

Avon Products ( AVP) numbers cut at Citigroup. Shares of AVP now seen reaching $18, Citigroup said. Estimates also lowered on weak guidance. Buy rating.

Burger King ( BKW) numbers raised at Credit Suisse. Shares of BKW now seen reaching $16.50, according to Credit Suisse. Estimates also increased, as the company is seeing higher international sales. Neutral rating.

Bristol Myers Squibb ( BMY) target cut at UBS to $34, UBS said. Company stumbles in HCV race. Neutral rating.

Cavium ( CAVM) numbers raised at Jefferies. Shares of CAVM now seen reaching $37, Jefferies said. Estimates also raised on solid quarter. Buy rating.

Comcast ( CMCSA) numbers raised at Jefferies. Shares of CMCSA now seen reaching $40, Jefferies said. Estimates also raised on solid cable-com segment. Buy rating.

Concur ( CNQR) estimates, target boosted at Credit Suisse. Shares of CNQR now seen reaching $79, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins.

Con-Way ( CNW) numbers reduced at Credit Suisse. Shares of CNW now seen reaching $38, according to Credit Suisse. Estimates also cut, given the macro environment and a higher tax rate. Outperform rating.

Devon Energy ( DVN) numbers lowered at Jefferies. Shares of DVN now seen reaching $89, Jefferies said. Estimates also lowered on some near- term headwinds. Buy rating.

Guess ( GES) estimates, target reduced at Piper. GES estimates were cut through 2014, Piper Jaffray said. Summer trends appear bleak and the company is hurt by the weaker Euro. Neutral rating and new $27 price target.

Green Mountain ( GMCR) numbers lowered at Keybanc.GMCR estimates were cut through 2013, Keybanc said. Company reduced its guidance. Buy rating and new $36 price target.

Hospira ( HSP) numbers cut at Citigroup. Shares of HSP now seen reaching $31, Citigroup said. Estimates also lowered on risk to 2013 Street views that discount an unrealistic profitability rebound. Sell rating.

World Fuel ( INT) numbers cut at Credit Suisse. INT estimates were reduced through 2013, Credit Suisse said. Management expects lower near-term margins. Outperform rating and new $48 price target.

Time Warner ( TWX) numbers raised at Morgan Stanley. Shares of TWX now seen reaching $44, according to Morgan Stanley. Estimates also increased, given higher expected domestic affiliate growth. Equal-weight rating.

Weight Watchers ( WTW) numbers cut at Credit Suisse. Shares of WTW now seen reaching $74, according to Credit Suisse. Estimates also reduced, as the company is seeing lower consumer spending. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

The Best Investment Advice? Stay Diversified

The Best Investment Advice? Stay Diversified

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many